The mind shrinkage noticed in Alzheimer’s could also be prevented by semaglutide, the drug in Ozempic
ZEPHYR/Science Photograph Library/Alamy
Ozempic and Wegovy are already remodeling how we deal with sort 2 diabetes and weight problems, and from subsequent yr one other situation affecting hundreds of thousands of individuals worldwide could be added to the checklist: Alzheimer’s illness.
Two medical trials investigating semaglutide, the drug in Ozempic and Wegovy, as a remedy for early Alzheimer’s are anticipated to conclude in 2025. If the outcomes are constructive, it might mark a breakthrough in treating this intractable situation.
